Welcome to our dedicated page for Cimpress Plc SEC filings (Ticker: CMPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Cimpress plc (NASDAQ: CMPR), an Ireland-based print mass-customization company in the commercial printing and manufacturing sector. Cimpress files periodic and current reports, proxy statements and other documents that describe its financial condition, governance and shareholder matters.
Among the key filings for CMPR are annual reports on Form 10-K, which include audited financial statements and detailed discussion of Cimpress’ print mass-customization businesses and brands such as VistaPrint, WIRmachenDRUCK, Pixartprinting, Pens.com, BuildASign, druck.at, Drukwerkdeal, easyflyer, Exaprint, Packstyle, Printi, Tradeprint, BoxUp and National Pen. Quarterly results and related information are often furnished via Form 8-K, where Cimpress has reported the posting of its quarterly earnings documents for fiscal year 2025 and fiscal year 2026 periods.
Cimpress also files a definitive proxy statement on Schedule 14A, which outlines proposals for its Annual General Meeting of Shareholders. The DEF 14A describes matters such as director reappointments, advisory votes on executive compensation, renewal of share issuance authorities under Irish law, and the appointment and remuneration of its statutory auditor, PricewaterhouseCoopers Ireland. It also provides information about the Board of Directors, corporate governance and compensation practices.
On Stock Titan, CMPR’s filings are updated from the SEC’s EDGAR system and paired with AI-powered summaries that highlight the main points of lengthy documents. Users can quickly understand the themes in Cimpress’ 10-K, 10-Q and 8-K filings, as well as proxy materials, without reading every page. Filings related to results of operations, governance decisions and other material events are organized in one place so investors can review Cimpress’ regulatory history and disclosures efficiently.
Morgan Stanley Smith Barney LLC filed a Form 144 reporting proposed sales of Common Stock tied to issuer awards and an option exercise. The entry lists planned dispositions including 960 restricted shares, 1,909 performance shares, additional restricted/performance grants totaling 6,382 across 2024–2025 dates, and a 10,000 share stock option exercise on 05/05/2026 for cash.
Spruce House-affiliated investors report owning just over 5% of Cimpress plc’s ordinary shares. The filing states that Spruce House entities collectively may be deemed beneficial owners of 1,222,633 shares of Cimpress, based on 24,232,090 shares outstanding as of April 27, 2026.
Individuals Zachary Sternberg and Benjamin Stein each report direct holdings of 17,873 and 16,805 shares, respectively, plus shared voting and dispositive power over the 1,222,633 shares held by The Spruce House Partnership LLC. Sternberg also holds 5,128 unvested performance stock units that are excluded from these ownership calculations.
The group notes it may be deemed a “person” or “group” under Section 13(d)(3), but each reporting person disclaims beneficial ownership beyond their pecuniary interest. The filing also states there have been no Cimpress share transactions by these reporting persons in the past 60 days.
Cimpress plc reported strong third‑quarter fiscal 2026 results, with revenue rising to $886.2 million, up 12% from a year earlier, driven by growth across all five segments and contributions from a tuck‑in acquisition in the PrintBrothers group.
Net income swung to a profit of $14.6 million from a loss of $8.0 million, and diluted EPS improved to $0.55 from a loss of $0.33. Year to date, revenue reached $2.79 billion, up 10%, while net income grew to $70.7 million. Adjusted EBITDA increased to $100.5 million for the quarter and $338.1 million year to date, helped by higher gross profit, cost improvements and favorable currency, partially offset by increased operating expenses and North American production start‑up costs.
Cimpress generated $173.2 million of operating cash flow year to date, down from $190.6 million, as working capital and higher cash taxes offset earnings growth. The company ended the quarter with $189.0 million in cash, $1.59 billion of debt and a shareholders’ deficit of $524.1 million.
Cimpress plc furnished an update on its recent performance by posting its Q3 Fiscal Year 2026 Quarterly Earnings Document on its website. This document covers financial results for the fiscal quarter ended March 31, 2026 and is attached as Exhibit 99.1.
The company is using this Form 8-K to make investors aware of the availability of that earnings document. Cimpress notes that the earnings materials and this related disclosure are being furnished, not filed, which limits their exposure to certain Exchange Act liabilities and incorporation by reference rules.
Cimpress plc executive Florian Baumgartner exercised restricted share units that converted into ordinary shares as part of his equity compensation. On this date, 9,288 RSUs were exercised into ordinary shares, with 4,411 shares withheld at a price of $80.49 per share to cover tax obligations. Following these transactions, Baumgartner directly held 68,720 Cimpress ordinary shares. The filing reflects routine vesting and tax withholding activity rather than open-market buying or selling.
Cimpress plc announced that its Board of Directors has authorized a new share repurchase program for up to $200,000,000 aggregate purchase price of its issued and outstanding ordinary shares. The authorization has no expiration date and allows repurchases on the open market, through privately negotiated transactions, or via one or more self-tender offers.
This new authorization replaces the remaining unused portion of the prior repurchase authorization approved on May 29, 2024, which was terminated immediately before the new program took effect. The Board emphasized that Cimpress is not required to use the full authorized amount and that repurchases are subject to its net leverage and near-term capital allocation commentary from its January 29, 2026 earnings document and may be suspended or discontinued at any time.
Cimpress PLC ownership disclosure: The Vanguard Group amended its Schedule 13G to report zero beneficial ownership of Cimpress PLC common stock following an internal realignment effective January 12, 2026.
The filing states Vanguard's subsidiaries/business divisions will report holdings separately in reliance on SEC Release No. 34-39538; the reported position shows 0 shares (0%) and zero voting or dispositive power.
Cimpress plc CEO and Chairman Robert S. Keane reported equity award activity involving performance share units (PSUs) and ordinary shares. On February 15, 2026, PSUs were exercised or converted into ordinary shares in several blocks, including 9,578, 146, and 3,388 PSUs at a price of $0.00 per unit, reflecting automatic vesting based on performance conditions.
Corresponding ordinary share entries show Keane acquiring the same amounts of ordinary shares through derivative exercise. In a separate transaction coded F, 4,117 ordinary shares at $74.27 per share were disposed of to satisfy tax obligations related to these awards. After these transactions, Keane directly owned 74,087 ordinary shares. The filing also notes additional ordinary shares held indirectly through entities such as RHS Delaware Holdings LLC and several related LLCs and trusts.
Cimpress plc EVP & Chief Technology Officer Maarten Wensveen reported equity award vesting and related share movements. On February 15, 2026, he acquired a total of 6,860 ordinary shares through automatic vesting and conversion of restricted share units and performance share units at no exercise price.
Following these transactions, including a 2,063-share tax-withholding disposition at $74.27 per share, Wensveen directly held 28,925 Cimpress ordinary shares. The footnotes explain that each RSU and PSU represented Cimpress’ commitment to issue one ordinary share, vesting over a four-year schedule.
Cimpress plc EVP and CFO Sean Edward Quinn reported equity award activity on February 15, 2026. He acquired 2,300 ordinary shares from vested restricted share units and 6,222 ordinary shares from vested performance share units through derivative exercises at $0.00 per share. To satisfy tax obligations, 2,546 ordinary shares were disposed of at $74.27 per share. After these transactions, he directly owned 46,859 ordinary shares.